Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

4.27
Delayed Data
As of Sep 25
 -0.30 / -6.56%
Today’s Change
4.24
Today|||52-Week Range
12.66
-40.36%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close4.57
Today’s open4.60
Day’s range4.24 - 4.63
Volume2,360,493
Average volume (3 months)725,671
Market cap$187.7M
Dividend yield--
Data as of 3:59pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)-23.81%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales71.69
Price/Book1.53

Competitors

 Today’s
change
Today’s
% change
IMDZImmune Design Corp-0.15-1.43%
SNDXSyndax Pharmaceutica...+0.07+0.62%
NERVMinerva Neuroscience...+0.05+0.72%
ZGNXZogenix Inc-0.85-5.90%
Data as of 4:00pm ET, 09/25/2017

Financials

Next reporting dateJanuary 8, 2018
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$4.0M
Annual profit (last year)-$73.6M
Net profit margin-1,841.27%

Profile

Sector
Health Technology
Industry
Biotechnology
EVP, Chief Executive &
Business Officer
Anthony A. Lombardo
Chief Operating Officer &
Senior Vice President
Christopher M. Duke
Corporate headquarters
Princeton, New Jersey

Forecasts